[Information about cancer treatment and the media].
A 'hopeful' development in cancer treatment (angiostatin) was reported in the Dutch press, which led to considerable disquiet amongst patients. There were no scientific articles that warranted this press publication. It has previously been stated that it is unethical for medical researchers to inform the press about treatments which have not been scrutinized by the medical community. The press on the other hand, should maintain a more responsible attitude toward medical claims and double-check medical information, even when it comes from renowned medical researchers. The main distinction between mainstream medicine and medical quackery is that the former is based on the results of controlled published research. When physicians propagate results in the popular press that have not been critically evaluated by the medical community, the distinction between quackery and mainstream medicine is undermined.
van Dam
F S A M
FS
fvandam@nki.nl
Renckens
C N M
CN
D043168:Angiostatins; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008402:Mass Media / Q000592:standards*; D009369:Neoplasms / Q000188:drug therapy*; D010446:Peptide Fragments / Q000627:therapeutic use*; D010958:Plasminogen / Q000627:therapeutic use*; D011781:Quackery
D000970:Antineoplastic Agents; D010446:Peptide Fragments; D043168:Angiostatins; D010958:Plasminogen
Voorlichting over kankerbehandeling en de media.